Evaluation of Bacteriophage ?11 host recognition protein and its host-binding peptides for diagnosing/targeting Staphylococcus aureus infections

dc.contributor.authorDokuz, Senanur
dc.contributor.authorTasdurmazli, Semra
dc.contributor.authorAcar, Tayfun
dc.contributor.authorDuran, Gizem Nur
dc.contributor.authorOzdemir, Cilem
dc.contributor.authorOzbey, Utku
dc.contributor.authorOzbil, Mehmet
dc.date.accessioned2025-10-29T11:27:30Z
dc.date.issued2024
dc.departmentEnstitüler, Lisansüstü Eğitim Enstitüsü, Biyomühendislik Ana Bilim Dalı
dc.description.abstractBackground: Evaluating the potential of using both synthetic and biological products as targeting agents for the diagnosis, imaging, and treatment of infections due to particularly antibiotic-resistant pathogens is important for controlling infections. This study examined the interaction between Gp45, a receptor-binding protein of the phi 11 lysogenic phage, and its host Staphylococcus aureus (S. aureus), a common cause of nosocomial infections. Methods: Using molecular dynamics and docking simulations, this study identified the peptides that bind to S. aureus wall teichoic acids via Gp45. It compared the binding affinity of Gp45 and the two highest-scoring peptide sequences (P1 and P3) and their scrambled forms using microscopy, spectroscopy, and ELISA. Results: It was found that rGp45 (recombinant Gp45) and chemically synthesised P1 had a higher binding affinity for S. aureus compared with all other peptides, except for Escherichia coli. Furthermore, rGp45 had a capture efficiency of > 86%; P1 had a capture efficiency of > 64%. Conclusion: These findings suggest that receptor-binding proteins such as rGp45, which provide a critical initiation of the phage life cycle for host adsorption, might play an important role in the diagnosis, imaging, and targeting of bacterial infections. Studying such proteins could accordingly enable the development of effective strategies for controlling infections. (c) 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
dc.description.sponsorshipScientific and Technological Research Council of Turkiye (TUBITAK) [120R016]
dc.description.sponsorshipWe would like to thank the Scientific and Technological Research Council of Turkiye (TUBITAK) for financial support this study, under project number 120R016 .
dc.identifier.doi10.1016/j.ijantimicag.2024.107230
dc.identifier.issn0924-8579
dc.identifier.issn1872-7913
dc.identifier.issue2
dc.identifier.pmid38824973
dc.identifier.scopus2-s2.0-85198101123
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.ijantimicag.2024.107230
dc.identifier.urihttps://hdl.handle.net/20.500.14854/10744
dc.identifier.volume64
dc.identifier.wosWOS:001268955500001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofInternational Journal of Antimicrobial Agents
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20251020
dc.subjectReceptor binding protein
dc.subjectTargeting peptide
dc.subjectPhi 11 phage
dc.subjectStaphylococcus aureus
dc.subjectAntimicrobial resistance
dc.titleEvaluation of Bacteriophage ?11 host recognition protein and its host-binding peptides for diagnosing/targeting Staphylococcus aureus infections
dc.typeArticle

Dosyalar